Literature DB >> 36161646

The analysis of pleural complications of COVID-19 pneumonia.

Merve Şatır Türk1, Irmak Akarsu1, İsmail Tombul1, Aykut Kankoç1, Nur Dilvin Özkan1, Elgün Veliyev1, Muhammet Sayan1, Ali Çelik1, İsmail Cüneyt Kurul1, Olgun Kadir Arıbaş1, Abdullah İrfan Taştepe1.   

Abstract

BACKGROUND: As the number of case reports related to the new type of coronavirus (COVID-19) increases, knowledge of and experience with the virus and its complications also increase. Pleural complications are one relevant issue. We aimed in this study to analyze pleural complications, such as pneumothorax, pneumomediastinum, and empyema, in patients hospitalized with the diagnosis of COVID-19 pneumonia.
METHODS: The files of patients who have pleural complications of COVID-19 pneumonia and were consulted about thoracic surgery between March 2020 and December 2020 were retrospectively reviewed. The data of the patients were analyzed according to age, sex, length of stay, treatment method for pleural complications, mortality, severity of COVID-19 pneumonia, tube thoracostomy duration, and presence of a mechanical ventilator.
RESULTS: A total of 31 patients fulfilling the inclusion criteria were included in the study. There were 11 female (35.5%) and 20 male (65.5%) patients. The most common complication was pneumothorax in 20 patients (65%). The median duration of hospitalization was 22 days and the mortality rate was 71%. Mortality was significantly higher in patients on mechanical ventilation (p = 0.04). DISCUSSION: The mortality rate is very high in patients with pleural complications of COVID-19 pneumonia. Pneumothorax is a fatal complication in critically ill patients with COVID-19 pneumonia.

Entities:  

Keywords:  COVID-19; Pneumothorax; empyema; pandemic; pneumomediastinum

Mesh:

Year:  2021        PMID: 36161646     DOI: 10.3906sag-2012-268

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   2.925


  1 in total

1.  Tracheo-esophageal fistula and pleural empyema in the course of SARS-CoV-2 infection-A case report.

Authors:  Hanna Kubik; Wiktoria Smyła; Mikołaj Herba; Szymon Białka; Mateusz Rydel
Journal:  Clin Case Rep       Date:  2022-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.